Therapy News and Research

RSS

Severe symptoms result in high titers of SARS-CoV-2 antibodies

Scientists have focused on determining the cause-effect relationship between SARS-CoV-2 antibody titers and COVID-19 disease severity.

9 May 2022

Gene therapy effectively reduces neuropathic pain in mice with spinal cord injuries

An international team of researchers, led by scientists at University of California San Diego School of Medicine, report that a gene therapy that inhibits targeted nerve cell signaling effectively reduced neuropathic pain with no detectable side effects in mice with spinal cord or peripheral nerve injuries.

9 May 2022

Urgent action needed to address disparities in women’s heart health

Investing in and improving research, awareness and equity in women's heart health are critical for the health and well-being of women, according to a new Presidential Advisory from the American Heart Association, published today in the Association's flagship journal Circulation.

9 May 2022

Healthy Mediterranean diet helps young men to beat depression

Depression is a common mental health condition that affects approximately 1 million Australians each year. It is a significant risk factor for suicide, the leading cause of death in young adults.

9 May 2022

Celebrating contributions to Alzheimer’s research and clinical care

The Mesulam Center for Cognitive Neurology and Alzheimer's Disease held the 28th annual Alzheimer Day on May 5, returning to campus for the first time in three years.

9 May 2022

T cell behavior informs metastatic melanoma outcomes

Immunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn't work, and new research may help explain why.

9 May 2022

Mathematical modeling reveals important factors that govern the effectiveness of adaptive therapy

Most cancer treatments are based on using the maximum tolerated dose of a drug to kill as many cancer cells as possible.

9 May 2022

Targeting interleukin-6 could help reduce immune-related adverse events from immunotherapy

Researchers at The University of Texas MD Anderson Cancer Center have identified a novel strategy to reduce immune-related adverse events from immunotherapy treatment by targeting the cytokine interleukin-6 (IL-6).

9 May 2022

Personal construct therapy found to be effective in reducing depression in women with fibromyalgia

Fibromyalgia is a rheumatic disease of unknown origin, which is characterized by chronic pain and often accompanied by symptoms of depression. It mainly affects women, and there is no cure, but various treatments can help relieve the symptoms.

9 May 2022

Researchers make breakthrough in overcoming drug resistance in a rare, devastating blood cancer

South Australian scientists have made a significant breakthrough in overcoming drug resistance in acute myeloid leukemia (AML), a rare and devastating blood cancer that kills most patients within a few years.

9 May 2022

Deoxyribonucleic acid nanostructure sensor found to rapidly detect and inhibit SARS-CoV-2

Researchers reported on a three-layer designer deoxyribonucleic acid (DNA) nanostructure (DDN) strategy-based sensor designed by them for rapid and accurate SARS-CoV-2 detection and inhibition.

9 May 2022

Differences in COVID-19 outcomes related to sex

Researchers looked at gender variations in COVID-19 outcomes such as hospitalization, ICU admission, mortality, and heart damage.

9 May 2022

The families of trans kids in Texas consider their options amid crackdown on care

Cameron Wright, 16, has always seen himself as a "dude." As a young child, Cameron didn't have the words to explain the disconnect between how he saw himself and how the world saw him. But he knew that despite being born in a girl's body, he was meant to be a boy.

9 May 2022

Study investigates the cause of lymphopenia as seen in COVID-19 patients

Researchers explored the underlying mechanism resulting in thymic atrophy and subsequent lymphopenia in COVID-19 patients.

9 May 2022

How new Insights into ESR1 Mutant Breast Cancers may lead to Novel Therapy Targets

In this interview, we speak to Steffi Oesterreich, PH.D., from the University of Pittsburgh, about how new insights into a gene mutation present in 20-30% of breast cancer recurrences may have a silver lining, leading to novel treatment opportunities.

9 May 2022

Research opens the door to novel therapies for cancer induced by hedgehog signaling pathway

A research led by Hong Kong University of Science and Technology has revealed a novel mechanism that regulates secretion of sonic hedgehog (Shh), a key signaling molecular that plays an important role in cancer progression, in mammals, opening the door to novel therapeutic strategies for cancer induced by the hedgehog signaling pathway.

9 May 2022

Benefit from convalescent plasma shown in COVID outpatient trial

Researchers have conducted a double-blind, multicentre, randomized, controlled trial, which is known as Convalescent Plasma to Limit SARS-CoV-2 Associated Complications Study to evaluate if early COVID-19 plasma treatment could reduce disease progression and, thereby, reduce hospitalization rate.

9 May 2022

Cedars-Sinai geriatricians create program to catch at-risk older adults before they fall

Falls and broken bones are common among older adults, but they're not a natural part of aging. That's why Cedars-Sinai geriatricians created a bone health and falls risk consultation program to catch at-risk people before they break a bone or help them avoid another fracture in the future.

6 May 2022

Study reveals underlying signaling pathway that results in pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the lungs, in which blood vessels are narrowed, blocked or destroyed, causing the heart to work harder and, in time, result in cardiac weakness and failure.

6 May 2022

Coaching program reduces emotional exhaustion and imposter syndrome among resident physicians

A coaching program aimed at decreasing burnout among female resident physicians significantly reduced emotional exhaustion and imposter syndrome while increasing self-compassion over a six month period, according to researchers at the University of Colorado Anschutz Medical Campus.

6 May 2022

Therapy News and Research

Severe symptoms result in high titers of SARS-CoV-2 antibodies

Gene therapy effectively reduces neuropathic pain in mice with spinal cord injuries

Urgent action needed to address disparities in women’s heart health

Healthy Mediterranean diet helps young men to beat depression

Celebrating contributions to Alzheimer’s research and clinical care

T cell behavior informs metastatic melanoma outcomes

Mathematical modeling reveals important factors that govern the effectiveness of adaptive therapy

Targeting interleukin-6 could help reduce immune-related adverse events from immunotherapy

Personal construct therapy found to be effective in reducing depression in women with fibromyalgia

Researchers make breakthrough in overcoming drug resistance in a rare, devastating blood cancer

Deoxyribonucleic acid nanostructure sensor found to rapidly detect and inhibit SARS-CoV-2

Differences in COVID-19 outcomes related to sex

The families of trans kids in Texas consider their options amid crackdown on care

Study investigates the cause of lymphopenia as seen in COVID-19 patients

How new Insights into ESR1 Mutant Breast Cancers may lead to Novel Therapy Targets

Research opens the door to novel therapies for cancer induced by hedgehog signaling pathway

Benefit from convalescent plasma shown in COVID outpatient trial

Cedars-Sinai geriatricians create program to catch at-risk older adults before they fall

Study reveals underlying signaling pathway that results in pulmonary arterial hypertension

Coaching program reduces emotional exhaustion and imposter syndrome among resident physicians

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News